Table 5.
Psychiatric conditions and treatment
| PSYCHIATRIC CONDITION OR TREATMENT |
SITE, N (%)
|
TOTAL COHORT (N = 102), N (%) | P VALUE | ||
|---|---|---|---|---|---|
| TORONTO (N = 44) | VANCOUVER (N = 36) | MONTREAL (N = 22) | |||
| Psychiatric condition | |||||
| • Major depression | 16 (36) | 21 (58) | 9 (41) | 46 (45) | .131 |
| • Anxiety disorder | 14 (32) | 5 (14) | 2 (9) | 21 (21) | .058 |
| • Other* | 5 (11) | 8 (22) | 4 (18) | 17 (17) | .429 |
| • Abuse (physical or sexual) | 21 (48) | 12 (33) | 3 (14) | 36 (35) | .023† |
| • Suicidal thoughts or attempts | 9 (20) | 5 (14) | 1 (5) | 15 (15) | .224 |
| Current pharmacotherapy | |||||
| • Benzodiazepines | 6 (14) | 24 (67) | 5 (23) | 35 (34) | < .001† |
| • Antipsychotics | 0 (0) | 4 (11) | 0 (0) | 4 (4) | NA |
| • Other‡ | 16 (36) | 10 (28) | 9 (41) | 35 (34) | .552 |
NA—not applicable.
*
Includes schizophrenia, bipolar disorder, and eating disorders.
†
Indicates significant difference at P < .05.
‡
Consists of selective serotonin reuptake inhibitors, selective noradrenergic reuptake inhibitors, trazodone, and bupropion.